» Articles » PMID: 26745376

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2016 Jan 9
PMID 26745376
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody-dependent cellular cytotoxicity (ADCC) that may contribute to viral containment, we profiled an array of extra-neutralizing antibody effector functions across HIV-infected populations with varying degrees of viral control to define the characteristics of antibodies associated with spontaneous control. While neither the overall magnitude of antibody titer nor individual effector functions were increased in ECs, a more functionally coordinated innate immune-recruiting response was observed. Specifically, ECs demonstrated polyfunctional humoral immune responses able to coordinately recruit ADCC, other NK functions, monocyte and neutrophil phagocytosis, and complement. This functionally coordinated response was associated with qualitatively superior IgG3/IgG1 responses, whereas HIV-specific IgG2/IgG4 responses, prevalent among viremic subjects, were associated with poorer overall antibody activity. Rather than linking viral control to any single activity, this study highlights the critical nature of functionally coordinated antibodies in HIV control and associates this polyfunctionality with preferential induction of potent antibody subclasses, supporting coordinated antibody activity as a goal in strategies directed at an HIV-1 functional cure.

Citing Articles

HIV controllers: hope for a functional cure.

Deng Z, Yan H, Lambotte O, Moog C, Su B Front Immunol. 2025; 16:1540932.

PMID: 40070826 PMC: 11893560. DOI: 10.3389/fimmu.2025.1540932.


Combinatorial Fc modifications for complementary antibody functionality.

Bartsch Y, Webb N, Burgess E, Kang J, Lauffenburger D, Julg B MAbs. 2025; 17(1):2465391.

PMID: 39950649 PMC: 11834420. DOI: 10.1080/19420862.2025.2465391.


Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity.

Nohara J, Evangelous T, Berry M, Beck W, Mudrak S, Jha S Pathog Immun. 2025; 10(1):49-79.

PMID: 39911143 PMC: 11792536. DOI: 10.20411/pai.v10i1.734.


Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

Zhu X, Luo Z, Leonard R, Hamele C, Spreng R, Heaton N PLoS Pathog. 2025; 21(1):e1012878.

PMID: 39841684 PMC: 11753672. DOI: 10.1371/journal.ppat.1012878.


Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.

Yu F, Zhu Y, Li S, Hao L, Li N, Ye F Front Cell Infect Microbiol. 2024; 14:1488527.

PMID: 39717542 PMC: 11663751. DOI: 10.3389/fcimb.2024.1488527.


References
1.
Dugast A, Stamatatos L, Tonelli A, Suscovich T, Licht A, Mikell I . Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection. Eur J Immunol. 2014; 44(10):2925-37. PMC: 4311770. DOI: 10.1002/eji.201344305. View

2.
Chung A, Ghebremichael M, Robinson H, Brown E, Choi I, Lane S . Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med. 2014; 6(228):228ra38. DOI: 10.1126/scitranslmed.3007736. View

3.
Yates N, Liao H, Fong Y, deCamp A, Vandergrift N, Williams W . Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci Transl Med. 2014; 6(228):228ra39. PMC: 4116665. DOI: 10.1126/scitranslmed.3007730. View

4.
Liu F, Lopez Bergami P, Duval M, Kuhrt D, Posner M, Cavacini L . Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Res Hum Retroviruses. 2003; 19(7):597-607. DOI: 10.1089/088922203322230969. View

5.
Ahmad A, Morisset R, Thomas R, Menezes J . Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. J Acquir Immune Defic Syndr (1988). 1994; 7(5):428-37. View